Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Enrica Favini"'
Autor:
Cinzia Lanzi, Enrica Favini, Laura Dal Bo, Monica Tortoreto, Noemi Arrighetti, Nadia Zaffaroni, Giuliana Cassinelli
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-25 (2021)
Abstract Background Synovial sarcoma (SS) is an aggressive soft tissue tumor with limited therapeutic options in advanced stage. SS18-SSX fusion oncogenes, which are the hallmarks of SS, cause epigenetic rewiring involving histone deacetylases (HDACs
Externí odkaz:
https://doaj.org/article/258ac722b6dc4231a4a62b0a9178a243
Autor:
Cinzia Lanzi, Laura Dal Bo, Enrica Favini, Monica Tortoreto, Giovanni Luca Beretta, Noemi Arrighetti, Nadia Zaffaroni, Giuliana Cassinelli
Publikováno v:
Cancers, Vol 11, Iss 3, p 408 (2019)
Pazopanib is approved for treatment of advanced soft tissue sarcomas, but primary and secondary drug resistance limits its clinical utility. We investigated the molecular mechanisms mediating pazopanib resistance in human synovial sarcoma (SS) models
Externí odkaz:
https://doaj.org/article/80b7da7a62c74884bebda4580af91661
Autor:
Giuliana Cassinelli, Enrica Favini, Debora Degl'Innocenti, Alessandro Salvi, Giuseppina De Petro, Marco A. Pierotti, Franco Zunino, Maria Grazia Borrello, Cinzia Lanzi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 11, Iss 1, Pp 10-21 (2009)
Activation of the RET gene by chromosomal rearrangements generating RET/PTC oncogenes is a frequent, early, and causative event in papillary thyroid carcinoma (PTC). We have previously shown that, in human primary thyrocytes, RET/PTC1 induces a trans
Externí odkaz:
https://doaj.org/article/caadca12053a40ffaf77b15e1110869f
Autor:
Monica Tortoreto, Enrica Favini, Laura Dal Bo, Noemi Arrighetti, Nadia Zaffaroni, Giuliana Cassinelli, Cinzia Lanzi
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-25 (2021)
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-25 (2021)
Background Synovial sarcoma (SS) is an aggressive soft tissue tumor with limited therapeutic options in advanced stage. SS18-SSX fusion oncogenes, which are the hallmarks of SS, cause epigenetic rewiring involving histone deacetylases (HDACs). Promis
Autor:
Eugenio Scanziani, Sabina Pozzi, Giuliana Cassinelli, Enrica Favini, Michelandrea De Cesare, Laura Dal Bo, Cinzia Lanzi, Denis Cominetti, Daniele Lecis, Monica Tortoreto, Lucia Minoli, Israel Vlodavsky, Nadia Zaffaroni, Annamaria Naggi
Publikováno v:
Cancer Letters. 415:187-197
Synovial sarcoma (SS) is an aggressive tumor with propensity for lung metastases which significantly impact patients' prognosis. New therapeutic approaches are needed to improve treatment outcome. Targeting the heparanase/heparan sulfate proteoglycan
Autor:
Enrica Favini, Laura Dal Bo, Marcella De Maglie, Nadia Zaffaroni, Silvana Pilotti, Gianpaolo Dagrada, Giuliana Cassinelli, Franco Zunino, Monica Tortoreto, Cinzia Lanzi
Publikováno v:
Oncotarget
// Giuliana Cassinelli 1 , Enrica Favini 1 , Laura Dal Bo 1 , Monica Tortoreto 1 , Marcella De Maglie 2, 3 , Gianpaolo Dagrada 4 , Silvana Pilotti 4 , Franco Zunino 1 , Nadia Zaffaroni 1 , Cinzia Lanzi 1 1 Molecular Pharmacology Unit, Department of E
Autor:
Denis Cominetti, Monica Tortoreto, Enrica Favini, Giuseppe Giannini, Cinzia Lanzi, Nadia Zaffaroni, Giacomo Cossa, Valentina Zuco, Raffaella Cincinelli, Franco Zunino, Eugenio Scanziani, Paola Perego, Giuliana Cassinelli, Vittoria Castiglioni, Laura Gatti
Publikováno v:
Biochemical Pharmacology. 94:79-90
Non-Small Cell Lung Cancer (NSCLC) remains an aggressive and fatal disease with low responsiveness to chemotherapy, frequent drug resistance development and metastatic behavior. Platinum-based therapy is the standard of care for NSCLC with limited be
Autor:
Noemi Arrighetti, Giuliana Cassinelli, Giovanni Luca Beretta, Monica Tortoreto, Cinzia Lanzi, Nadia Zaffaroni, Laura Dal Bo, Enrica Favini
Publikováno v:
Cancers, Vol 11, Iss 3, p 408 (2019)
Cancers
Volume 11
Issue 3
Cancers
Volume 11
Issue 3
Pazopanib is approved for treatment of advanced soft tissue sarcomas, but primary and secondary drug resistance limits its clinical utility. We investigated the molecular mechanisms mediating pazopanib resistance in human synovial sarcoma (SS) models
Autor:
C. Pisano, Denis Cominetti, Monica Tortoreto, Enrica Favini, Giovanna Petrangolini, Franco Zunino, Sergio Penco, Cinzia Lanzi, Giuliana Cassinelli, Israel Vlodavsky, Nadia Zaffaroni
Publikováno v:
Biochemical Pharmacology. 85:1424-1432
The activity of heparanase is responsible for heparan sulfate cleavage, thus resulting in the release of heparan sulfate-bound growth factors. Since heparanase activity is upregulated in several tumor types and is implicated in the malignant behavior
Autor:
Enrica Favini, Valentina Nicolini, Monica Tortoreto, Franco Zunino, Giuliana Cassinelli, Piera Mondellini, Italia Bongarzone, Patrizia Casalini, Cinzia Lanzi, Nadia Zaffaroni, Giovanna Petrangolini, Giuditta Cuccuru
Publikováno v:
Biochemical Pharmacology. 82:778-788
Emerging evidence suggests that Ret oncoproteins expressed in medullary thyroid cancer (MTC) might evade the pro-apoptotic function of the dependence receptor proto-Ret by directly impacting the apoptosis machinery. Identification of the molecular de